NURITAS
Latest
NURITAS
MORE ARTICLES
Sarcopenia, or age-related muscle loss, is a primary cause of loss of physical independence in the elderly, and the focus of one recent Horizon-funded research study. “The need for effective treatment strategies that can slow or reverse age-related muscle loss is essential if a future crisis is to be avoided,” says Dr Robert Radford, project lead of Pept-AGE at Nuritas.
Read MoreNuritas recently moved into their new HQ at a landmark location in Dublin, befitting its growing status as a global leader in peptide research. As Managing Director Emmet Browne outlines, the company’s reputation is proving to be an invaluable asset on the crest of a wave.
Read More